Tsivia Hochman

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Rationale, study design and implementation of the LUCINDA Trial: Leuprolide plus Cholinesterase Inhibition to reduce Neurologic Decline in Alzheimer's”.

Rationale, study design and implementation of the LUCINDA Trial: Leuprolide plus Cholinesterase Inhibition to reduce Neurologic Decline in Alzheimer's

Contemporary Clinical Trials(2021)10.1016/j.cct.2021.106488

N/A

0DataRank · unranked

18 citations

Judith D. Goldberg, James E. Galvin, Thomas Maloney, Lisa Ravdin, Lidia Glodzik +5 more

Pembrolizumab (pembro) in combination with gemcitabine (Gem) and concurrent hypofractionated radiation therapy (RT) as bladder sparing treatment for muscle-invasive urothelial cancer of the bladder (MIBC): A multicenter phase 2 trial.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.4504

N/A

0DataRank · unranked

42 citations

Matthew I. Milowsky, Peter H. O’Donnell, Ajjai Alva, Marisa Kollmeier, Tracy L. Rose +15 more

Data from High Levels of Hsp90 Cochaperone p23 Promote Tumor Progression and Poor Prognosis in Breast Cancer by Increasing Lymph Node Metastases and Drug Resistance

(2023)10.1158/0008-5472.c.6500681

N/A

0DataRank · unranked

0 citations

W. Marcus Lambert, Renecia A. Watkins, Shah Giashuddin, S. Joseph Huang, Ellinor Oxelmark +9 more

Data from High Levels of Hsp90 Cochaperone p23 Promote Tumor Progression and Poor Prognosis in Breast Cancer by Increasing Lymph Node Metastases and Drug Resistance

(2023)10.1158/0008-5472.c.6500681.v1

N/A

0DataRank · unranked

0 citations

W. Marcus Lambert, Renecia A. Watkins, Shah Giashuddin, S. Joseph Huang, Ellinor Oxelmark +9 more

A Phase 2 Exploratory Trial Evaluating Computed Tomography–Based Midtreatment Nodal Response to Select for De-escalated Chemoradiation Therapy in the Definitive Management of p16+ Oropharyngeal Cancer

International Journal of Radiation Oncology*Biology*Physics(2025)10.1016/j.ijrobp.2025.09.054

N/A

0DataRank · unranked

0 citations

Moses Tam, Sungheon Kim, Eddy Solomon, C.K. Hill, Jerome M. Karp +15 more